Stewart W, Van Rooyen J, Cundiff G, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20(6):327–36. https://doi.org/10.1007/s00345-002-0301-4.

Article  CAS  PubMed  Google Scholar 

Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology. 2011;77(5):1081–7. https://doi.org/10.1016/j.urology.2010.08.039.

Article  PubMed  Google Scholar 

Sexton CC, Coyne KS, Thompson C, Bavendam T, Chen CI, Markland A. Prevalence and effect on health-related quality of life of overactive bladder in older Americans: results from the epidemiology of lower urinary tract symptoms study. J Am Geriatr Soc. 2011;59(8):1465–70. https://doi.org/10.1111/j.1532-5415.2011.03492.x.

Article  PubMed  Google Scholar 

Cameron AP, Chung DE, Dielubanza EJ, et al. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder. J Urol. 2024;212(1):11–20. https://doi.org/10.1097/JU.0000000000003985.

Article  PubMed  Google Scholar 

Amundsen CL, Sutherland SE, Kielb SJ, Dmochowski RR. Sacral and implantable tibial neuromodulation for the management of overactive bladder: a systematic review and meta-analysis. Adv Ther. 2025;42(1):10–35. https://doi.org/10.1007/s12325-024-03019-0.

Article  PubMed  Google Scholar 

Liu P, Li Y, Shi B, Zhang Q, Guo H. Comparison of different types of therapy for overactive bladder: a systematic review and network meta-analysis. Front Med. 2022;9:1014291. https://doi.org/10.3389/fmed.2022.1014291.

Article  Google Scholar 

Lo CW, Wu MY, Yang SSD, Jaw FS, Chang SJ. Comparing the efficacy of OnabotulinumtoxinA, sacral neuromodulation, and peripheral tibial nerve stimulation as third line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis. Toxins Basel. 2020;12(2):2. https://doi.org/10.3390/toxins12020128.

Article  CAS  Google Scholar 

Siddiqui NY, Wu JM, Amundsen CL. Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review. Neurourol Urodyn. 2010;29(S1):S18–23. https://doi.org/10.1002/nau.20786.

Article  PubMed  Google Scholar 

Tilborghs S, De Wachter S. Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects. Expert Rev Med Devices. 2022;19(2):161–87. https://doi.org/10.1080/17434440.2022.2032655.

Article  CAS  PubMed  Google Scholar 

Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175(3):835–41. https://doi.org/10.1016/S0022-5347(05)00326-5.

Article  PubMed  Google Scholar 

Averbeck MA, Gajewski JB, Finazzi-Agrò E, et al. Is our limited understanding of the effects of nerve stimulation resulting in poor outcomes and the need for better “rescue programming” in SNM and PTNS, and lost opportunities for new sites of stimulation? ICI-RS 2024. Neurourol Urodyn. 2025;44(3):676–82. https://doi.org/10.1002/nau.25600.

Article  PubMed  Google Scholar 

Schmidt RA, Tanagho EA. Feasibility of controlled micturition through electric stimulation. Urol Int. 1979;34(3):199–230. https://doi.org/10.1159/000280267.

Article  CAS  PubMed  Google Scholar 

Krhut J, Kobberø H, Kanaan R, Fode M, Poulsen M, Zvara P. The mechanism of action of neuromodulation in the treatment of overactive bladder. Nat Rev Urol. 2025;22(7):414–26. https://doi.org/10.1038/s41585-024-00967-8.

Article  PubMed  Google Scholar 

Dudding TC, Lehur PA, Sørensen M, et al. Reprogramming sacral neuromodulation for sub-optimal outcomes: evidence and recommendations for clinical practice. Neuromodulation. 2021;24(7):1247–57. https://doi.org/10.1111/ner.13494.

Article  PubMed  PubMed Central  Google Scholar 

Lehur PA, Sørensen M, Dudding TC, et al. Programming algorithms for sacral neuromodulation: clinical practice and evidence—recommendations for day-to-day practice. Neuromodulation. 2020;23(8):1121–9. https://doi.org/10.1111/ner.13117.

Article  PubMed  PubMed Central  Google Scholar 

Knowles CH, De Wachter S, Engelberg S, Lehur P, Matzel KE, Zirpel L. The science behind programming algorithms for sacral neuromodulation. Colorectal Dis. 2021;23(3):592–602. https://doi.org/10.1111/codi.15390.

Article  PubMed  Google Scholar 

Gill BC, Thomas S, Barden L, et al. Intraoperative predictors of sacral neuromodulation implantation and treatment response: results from the ROSETTA trial. J Urol. 2023;210(2):331–40. https://doi.org/10.1097/JU.0000000000003498.

Article  PubMed  PubMed Central  Google Scholar 

Jairam R, Drossaerts J, Marcelissen T, Van Koeveringe G, Vrijens D, Van Kerrebroeck P. Predictive factors in sacral neuromodulation: a systematic review. Urol Int. 2022;106(4):323–43. https://doi.org/10.1159/000513937.

Article  PubMed  Google Scholar 

Butson CR, McIntyre CC. Differences among implanted pulse generator waveforms cause variations in the neural response to deep brain stimulation. Clin Neurophysiol. 2007;118(8):1889–94. https://doi.org/10.1016/j.clinph.2007.05.061.

Article  PubMed  PubMed Central  Google Scholar 

Lempka SF, Howell B, Gunalan K, Machado AG, McIntyre CC. Characterization of the stimulus waveforms generated by implantable pulse generators for deep brain stimulation. Clin Neurophysiol. 2018;129(4):731–42. https://doi.org/10.1016/j.clinph.2018.01.015.

Article  PubMed  PubMed Central  Google Scholar 

Li M, Zhang N, Wu D, Jiang M, You S, Jia Y. Electric nerve stimulation for overactive bladder: an umbrella review. Int J Rehabil Res. 2021;44(4):298–306. https://doi.org/10.1097/MRR.0000000000000492.

Article  PubMed  Google Scholar 

Greenberg DR, Syan R, Young-Lin N, Comiter CV, Enemchukwu E. Outcomes of sacral nerve stimulation for treatment of refractory overactive bladder among octogenarians. Neuromodulation. 2019;22(6):738–44. https://doi.org/10.1111/ner.12981.

Article  PubMed  Google Scholar 

Komesu YM, Amundsen CL, Richter HE, et al. Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications. Am J Obstet Gynecol. 2018;218(1):111.e1-111.e9. https://doi.org/10.1016/j.ajog.2017.10.006.

Article  PubMed  Google Scholar 

Zillioux J, Slopnick EA, Vasavada SP. Third-line therapy for overactive bladder in the elderly: nuances and considerations. Neurourol Urodyn. 2022;41(8):1967–74. https://doi.org/10.1002/nau.24965.

Article  PubMed  PubMed Central  Google Scholar 

Mason MD, Stephany HA, Casella DP, et al. Prospective evaluation of sacral neuromodulation in children: outcomes and urodynamic predictors of success. J Urol. 2016;195(4 Part 2):1239–44. https://doi.org/10.1016/j.juro.2015.11.034.

Article  PubMed  Google Scholar 

Harvie HS, Amundsen CL, Neuwahl SJ, et al. Cost-effectiveness of sacral neuromodulation versus OnabotulinumtoxinA for refractory urgency urinary incontinence: results of the ROSETTA randomized trial. J Urol. 2020;203(5):969–77. https://doi.org/10.1097/JU.0000000000000656.

Article  PubMed  Google Scholar 

Sukhu T, Kennelly M, Kurpad R. Sacral neuromodulation in overactive bladder: a review and current perspectives. Res Rep Urol. 2016;8:193–9. https://doi.org/10.2147/RRU.S89544.

Article  PubMed  PubMed Central  Google Scholar 

Wang M, Jian Z, Ma Y, Jin X, Li H, Wang K. Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis. Int Urogynecol J. 2020;31(12):2457–71. https://doi.org/10.1007/s00192-020-04429-8.

Article  PubMed  Google Scholar 

Chughtai B, Clemens JQ, Thomas D, Sun T, Ghomrawi H, Sedrakyan A. Real world performance of sacral neuromodulation and OnabotulinumtoxinA for overactive bladder: focus on safety and cost. J Urol. 2020;203(1):179–84. https://doi.org/10.1097/JU.0000000000000462.

Article  PubMed  Google Scholar 

Hijaz A, Vasavada S. Complications and troubleshooting of sacral neuromodulation therapy. Urol Clin North Am. 2005;32(1):65–9. https://doi.org/10.1016/j.ucl.2004.09.001.

Article  PubMed